J. Rischke

发表

Aspirin inhibits platelet function independent of the acetylation of cyclo-oxygenase.

J. Hirsh, M. Buchanan, J. Rischke, 1982, Thrombosis research.

Effect of nonspecific binding to plasma proteins on the antithrombin activities of unfractionated heparin, low-molecular-weight heparin, and dermatan sulfate.

J. Hirsh, B. Cosmi, J. Weitz, 1997, Circulation.

Effects of misoprostol on the pharmacokinetics of indomethacin in human volunteers

R. Hunt, R. Hunt, G. Hantsbarger, 1992, Clinical pharmacology and therapeutics.

Identification of the Mechanism Responsible for the Increased Fibrin Specificity of TNK-Tissue Plasminogen Activator Relative to Tissue Plasminogen Activator*

B. Keyt, J. Weitz, B. Leslie, 2000, The Journal of Biological Chemistry.

Biological action of colorless and yellow solutions of gold sodium thiomalate on thrombin activity and the mixed lymphocyte reaction.

Y. Kassam, W. Kean, C. Lock, 1988, Journal of pharmaceutical sciences.

In vitro comparison of the effect of heparin, enoxaparin and fondaparinux on tests of coagulation.

J. Hirsh, J. Julian, J. Weitz, 2002, Thrombosis research.

Antithrombin activity of gold sodium thiomalate

W. Buchanan, Y. Kassam, W. Kean, 1984, Clinical pharmacology and therapeutics.

Effect of R and S enantiomers of naproxen on aggregation and thromboxane production in human platelets.

W. Buchanan, W. Kean, C. Lock, 1989, Journal of pharmaceutical sciences.

Action of gold sodium thiomalate on experimental thrombosis in vivo.

W. Buchanan, Y. Kassam, W. Kean, 1991, Journal of pharmaceutical sciences.

A biological effect on platelets by the minor component of gold sodium thiomalate--a by-product of heat sterilization and exposure to light.

W. Buchanan, Y. Kassam, P. Rooney, 1984, Clinical and experimental rheumatology.

Thrombin-activable Fibrinolysis Inhibitor Attenuates (DD)E-mediated Stimulation of Plasminogen Activation by Reducing the Affinity of (DD)E for Tissue Plasminogen Activator

J. Weitz, J. Fredenburgh, L. Bajzar, 2000, The Journal of Biological Chemistry.

The sex-related differences in aspirin pharmacokinetics in rabbits and man and its relationship to antiplatelet effects.

J. Hirsh, A. Turpie, J. Rosenfeld, 1983, Thrombosis research.

Like Fibrin, (DD)E, the Major Degradation Product of Crosslinked Fibrin, Protects Plasmin from Inhibition by α2-antiplasmin

J. Weitz, J. Fredenburgh, R. Stewart, 2001, Thrombosis and Haemostasis.

Incorporation of fragment X into fibrin clots renders them more susceptible to lysis by plasmin.

J. Weitz, B. Leslie, J. Fredenburgh, 2006, Biochemistry.